Flexion Therapeutics on Friday earned Food and Drug Administration approval for Zilretta, an extended-release treatment for osteoarthritis knee pain. Here are three things to know. 1. Zilretta is ...
The FDA approved Flexion Therapeutics’ Zilretta, an intra-articular therapy for osteoarthritis knee pain. 1. Flexion is marketing the drug as the first and only extended-release intra-articular ...
Burlington, MA-based Flexion ($FLXN) says that the FDA has lifted its clinical hold on its lead pain drug candidate, FX006. The biotech reports that had completed the ...
Post-hoc analysis demonstrates potential of ZILRETTA ® (triamcinolone acetonide extended-release injectable suspension) to provide effective pain relief regardless of prior intra-articular ...
Flexion Therapeutics Inc. shares traded 60% higher after the company reported it entered into a definitive agreement to be acquired by Pacira BioSciences Inc. for $8.00 per share in cash plus an ...
Medically reviewed by Oluseun Olufade, MD Key Takeaways Spinal stenosis exercises can strengthen muscles and alleviate pain.The knees-to-chest stretch helps relieve spine compression pain.The child's ...